Abametapir | Interleukin Related interleukin-related.com

Product Name :
Abametapir

Search keywords :
Abametapir

drugId :
null

Target Vo:
Metalloproteases

Target Vo Short Name :
Metalloproteases

Moa_Name:
Metalloproteases inhibitors

First Approval Country :
United States

First Approval Date Filter:
2020

Origin Company_Name :
Hatchtech Pty Ltd

Active Company_Name :

Active Indication_Name:

In Active Indication_Name:
Lice Infestations

Termination Status :

China Termination Status :

Highest Status:
Withdrawn

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Bamlanivimab Cancer
SOD2 Rabbit mAb site
CDC42EP1 Antibody: CDC42EP1 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 40 kDa, targeting to CDC42EP1. It can be used for WB assays with tag free, in the background of Human.

Author: Interleukin Related

Related Posts